IMAC IMAC Holdings

IMAC Holdings to Present at the LD Micro 500 Virtual Conference on September 1, 2020

IMAC Holdings to Present at the LD Micro 500 Virtual Conference on September 1, 2020

BRENTWOOD, Tenn., Aug. 25, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced that Jeff Ervin, President and Chief Executive Officer, will give a virtual corporate presentation at the LD Micro 500 taking place online on Tuesday, September 1, 2020 at 9:00 AM ET followed by a live Q&A session with registered investors and other conference attendees.

Webcast link:

In addition, Mr. Ervin will be available for virtual one-on-one meetings from September 1-4, 2020. To schedule a meeting please contact Eric Lahiji at .

About IMAC Holdings, Inc.

IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, as well as Mike Ditka IMAC Regeneration Centers and a Tony Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids. More information about IMAC Holdings, Inc. is available at .

# # #

Safe Harbor Statement

This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.

IMAC Press Contact:

Laura Fristoe

IMAC Investor Contact:

Bret Shapiro

(516) 222-2560

Source: IMAC Holdings, Inc.

EN
25/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMAC Holdings

 PRESS RELEASE

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirement...

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market and that it is in compliance with all applicable listing standards. The Company’s common stock and warrants will continue to be listed and traded on The N...

 PRESS RELEASE

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the Company’s Certificate of Incorporation in order to effect the Reverse Split. The Reverse Split will be effective after the market closes on September 7, 2023. Beginning with the opening of trading on September 8, 2023, the Company’s common stock...

 PRESS RELEASE

IMAC Holdings Announces $4.3 Million Private Placement of Convertible ...

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities purchase agreement with several institutional and accredited investors, including existing significant investors of Theralink Technologies, Inc., its previously announced merg...

 PRESS RELEASE

IMAC Holdings Annual Meeting of Shareholders Reminder

IMAC Holdings Annual Meeting of Shareholders Reminder Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual Meeting will be held July 5, 2023 at 11:00 am, local time, in Franklin, Tennessee. IMAC shareholders are encouraged to read the Proxy ...

 PRESS RELEASE

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Ho...

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each solid tumor cancer Golden, Colorado, May 23, 2023 (GLOBE NEWSWIRE) -- , Inc. (OTC: THER) (“Theralink”) and IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), today announced that they have entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which Theralink will merg...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch